AMERICAN BIOMED, Minimally Invasive Technology (ABMI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Larry E Smith who wrote (604)	4/30/1998 5:05:00 PM
From: Jeffrey L. Henken	Read Replies (2) of 2887

Larry a couple of months ago I had my first conversation with Steve Rash(CEO of American BioMed) and I of course asked him many questions. One of those questions was about the quality of the distribution system that the company was putting into place. Steve picked Stepic Medical as an example of just how good these distributors actually are and proceeded to tell me that, "Stepic won't even sign on to distribute a company's products if they don't believe they can sell $2 million a year of their products." Well you know a couple of months has passed and that statement was kind of eating at me as I try to determine if ABMI shareholders can really expect some real revenue growth in the future so I decided to do a little independent research. What did I do? Well I started at the Stepic Medical website: stepic.com Once there I did a little reading attempting to find some information on the products that Stepic distributes. On page two of the Stepic Newsletter I found some information about another catheter company Arrow International: stepic.com Naturally I was a little taken back because at first blush this seems like direct competition and it may indeed be just that but it also shows one thing about Stepic Medical and that is they do have the ability to sell catheters! Look at some of the financial numbers on ARRO which closed at $33 today and dream along with me of better days ahead for ABMI shareholders. ARRO produces critical care products, mainly dispos-able catheters for access to the central vascular system for administration of fluids, drugs and blood products. Net sales for the six months ended 2/98 rose 8% to $130.5 million. Net income rose 19% to $20.8 million. Revenues reflect an increase in unit volume in the Company's central venous catheter products. Earnings also reflect reduced manufacturing costs due to increased production at international facilities. quote.yahoo.com GO ABMI! Regards, Jeff

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next